Literature DB >> 21688209

M cell-targeted mucosal vaccine strategies.

M Yamamoto1, D W Pascual, H Kiyono.   

Abstract

Immune responses in the aerodigestive tract are characterized by production and transport of specific IgA antibodies across the epithelium to act as a first line of defense against pathogens in the external environment. To sample antigens on mucosal surfaces in the intestine and upper respiratory tract, the immune system relies on a close collaboration between specialized antigen-sampling epithelial M cells and lymphoid cells. Depending on various factors, local antigen presentation in the mucosal tissue leads to tolerance or initiation of an active immune response. Recently, molecules that could be used to target vaccine antigens to apical M cell surfaces have been identified. Here we review the M cell-targeted vaccine strategy, an approach that could be used to enhance uptake and efficacy of vaccines delivered in the nasal cavity or intestine.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21688209      PMCID: PMC7393565          DOI: 10.1007/82_2011_134

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  71 in total

1.  Gene transfer facilitated by a cellular targeting molecule, reovirus protein sigma1.

Authors:  Y Wu; M J Boysun; K L Csencsits; D W Pascual
Journal:  Gene Ther       Date:  2000-01       Impact factor: 5.250

2.  Oral tolerance, an active immunologic process mediated by multiple mechanisms.

Authors:  H L Weiner
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

3.  Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyer's patches.

Authors:  Masayuki Tsuji; Noriko Komatsu; Shimpei Kawamoto; Keiichiro Suzuki; Osami Kanagawa; Tasuku Honjo; Shohei Hori; Sidonia Fagarasan
Journal:  Science       Date:  2009-03-13       Impact factor: 47.728

Review 4.  Immunological commonalities and distinctions between airway and digestive immunity.

Authors:  Jun Kunisawa; Tomonori Nochi; Hiroshi Kiyono
Journal:  Trends Immunol       Date:  2008-11       Impact factor: 16.687

5.  Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria.

Authors:  S Kernéis; A Bogdanova; J P Kraehenbuhl; E Pringault
Journal:  Science       Date:  1997-08-15       Impact factor: 47.728

Review 6.  Vaccination strategies for mucosal immune responses.

Authors:  P L Ogra; H Faden; R C Welliver
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

7.  Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin.

Authors:  David J M Lewis; Zhiming Huo; Susan Barnett; Ingrid Kromann; Rafaela Giemza; Eva Galiza; Maria Woodrow; Birgit Thierry-Carstensen; Peter Andersen; Deborah Novicki; Giuseppe Del Giudice; Rino Rappuoli
Journal:  PLoS One       Date:  2009-09-16       Impact factor: 3.240

Review 8.  Regulatory lymphocytes and intestinal inflammation.

Authors:  Ana Izcue; Janine L Coombes; Fiona Powrie
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

9.  Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland.

Authors:  Margot Mutsch; Weigong Zhou; Philip Rhodes; Matthias Bopp; Robert T Chen; Thomas Linder; Christian Spyr; Robert Steffen
Journal:  N Engl J Med       Date:  2004-02-26       Impact factor: 91.245

10.  Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement.

Authors:  Marcello Chieppa; Maria Rescigno; Alex Y C Huang; Ronald N Germain
Journal:  J Exp Med       Date:  2006-12-04       Impact factor: 14.307

View more
  8 in total

Review 1.  Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites.

Authors:  Mevyn Nizard; Mariana O Diniz; Helene Roussel; Thi Tran; Luis Cs Ferreira; Cecile Badoual; Eric Tartour
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

2.  Targeted nasal vaccination provides antibody-independent protection against Staphylococcus aureus.

Authors:  Karen Misstear; Edel A McNeela; Alison G Murphy; Joan A Geoghegan; Kate M O'Keeffe; John Fox; Kin Chan; Simon Heuking; Nicolas Collin; Timothy J Foster; Rachel M McLoughlin; Ed C Lavelle
Journal:  J Infect Dis       Date:  2013-11-22       Impact factor: 5.226

Review 3.  Lactococcus lactis : A New Strategy for Vaccination.

Authors:  Maryam Azizpour; Seyyed Davood Hosseini; Parvaneh Jafari; Neda Akbary
Journal:  Avicenna J Med Biotechnol       Date:  2017 Oct-Dec

4.  Microbial Stimulation Reverses the Age-Related Decline in M Cells in Aged Mice.

Authors:  David S Donaldson; Jolinda Pollock; Prerna Vohra; Mark P Stevens; Neil A Mabbott
Journal:  iScience       Date:  2020-05-11

5.  Characterization of M Cells in Tear Duct-Associated Lymphoid Tissue of Mice: A Potential Role in Immunosurveillance on the Ocular Surface.

Authors:  Yuki Oya; Shunsuke Kimura; Yutaka Nakamura; Narumi Ishihara; Shunsuke Takano; Ryo Morita; Mayumi Endo; Koji Hase
Journal:  Front Immunol       Date:  2021-11-22       Impact factor: 7.561

Review 6.  Gut health: The results of microbial and mucosal immune interactions in pigs.

Authors:  Jie Peng; Yimei Tang; Yanhua Huang
Journal:  Anim Nutr       Date:  2021-03-25

7.  Mucosal vaccine adjuvants update.

Authors:  Joon Haeng Rhee; Shee Eun Lee; Soo Young Kim
Journal:  Clin Exp Vaccine Res       Date:  2012-07-31

8.  Impacts of Salmonella enterica Serovar Typhimurium and Its speG Gene on the Transcriptomes of In Vitro M Cells and Caco-2 Cells.

Authors:  Ke-Chuan Wang; Chih-Hung Huang; Ching-Jou Huang; Shiuh-Bin Fang
Journal:  PLoS One       Date:  2016-04-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.